Navigation Links
SOMA 250 MG Shown To Significantly Improve Functionality and Reduce Disability in Patients With Low Back Pain in Three Days
Date:2/3/2010

nsive and increasingly popular approach to healthcare with goals of providing high quality care, controlling costs, and maximizing health care value based upon clinical quality and outcomes data.  This approach is increasingly influencing decisions on selection of treatment regimens, prescribing and reimbursement.  Promptly helping patients achieve clinical improvement in their functional status following acute musculoskeletal injuries is considered a key component of effective treatment and risk control strategies, and may contribute to a reduction in total healthcare costs.

"Overall, the greatest cost savings from a societal perspective may be obtained from interventions that promote early return to work and minimize lost productivity," said Al Moorad, MD, Medical Director, Integris Jim Thorpe Rehabilitation, Oklahoma City. "This may be accomplished by appropriate drug utilization to allow patients to actively participate in rehabilitation therapy and return to daily activities."

SOMA 250 mg Outcomes Data

SOMA 250 mg was studied in two multi-center, double-blind placebo-controlled clinical trials of more than 1300 subjects.  In these studies, the co-primary endpoints were met: patients receiving SOMA 250 mg reported a statistically significant improvement in global impression of change and relief from starting backache on day 3, the primary analysis, compared to placebo (P<0.0001).  

In these same studies, a secondary endpoint of patient functionality was measured.  Patients achieved significantly greater clinical improvement in functionality outcomes as measured by the Roland-Morris Disability Questionnaire (RMDQ) with SOMA 250 mg vs. placebo on day 3.  The Roland Morris Disability Questionnaire (RMDQ) is an internationally validated standard for measuring the degree of disability and functionality in
'/>"/>

SOURCE MEDA AB
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. RediClinic Offers Affordable New Plan Clinically Shown to Double a Persons Chance to Stop Smoking
2. SCH 530348 (TRA), a Novel Investigational Antiplatelet Agent, Shown to Inhibit Platelet Aggregation in PCI Patients
3. Divine Corporations Personal Lubricants Shown to Block Cancer-causing Viruses in a Study by the National Cancer Institute
4. Evotecs EVT 101 Shown to Penetrate the Brain in Man and to Modulate Brain Activity During the Performance of Cognitive Tasks
5. CERVARIX(R) Shown to Provide Longest Duration of Sustained Neutralizing Antibodies to Date
6. Olanzapine Long-Acting Injection (LAI) Shown to Maintain Treatment Benefit in Schizophrenia for up to Six Months
7. Protein Shown to Play a Key Role in Normal Development of Nervous System
8. SELECT TRIAL Used Selenomethionine Instead of High-Selenium Yeast, SelenoExcell(R) - Previous Research has Shown SelenoExcell(R) Supplementation to Reduce Lung, Colon and Prostate Cancers by as Much as 63%, Says Cypress Systems, Inc.
9. Isis Announces That OGX-011 Has Shown Overall Survival Advantage in Prostate Cancer Compared to Standard Therapy in a Randomized Phase 2 Study
10. MEDIHONEY(TM) Dressings Shown to Help Improve Outcomes of Non-Healing Venous Leg Ulcers in Recent Case Series
11. NovaBay Pharmaceuticals Announces Lead Anti-infective Product Candidate, NVC-422, Shown to be Effective in Treating Topical Fungal Infection
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2015)... , March 27, 2015 The International Myeloma ... myeloma patients while working toward prevention and a cure ... for introducing a federal resolution (H. Res. 174) that ... as "National Multiple Myeloma Awareness Month." Currently ... worldwide, and more than 110,000 new cases are diagnosed ...
(Date:3/27/2015)... , March 27, 2015  RXi Pharmaceuticals ... MirImmune LLC, today announced that they have ... RXi,s novel and proprietary sd-rxRNA® technology for ... The collaboration has the potential to result ... cancer treatments that could be a significant ...
(Date:3/27/2015)... , March 27, 2015 ... 2015" therapeutic market research report of 52 pages ... online business intelligence library. The report ... on the therapeutic development for Visceral Pain, complete ... by drug target, mechanism of action (MoA), route ...
Breaking Medicine Technology:The International Myeloma Foundation (IMF) Secures the Introduction of a Federal Resolution Recognizing March 2015 as "National Multiple Myeloma Awareness Month" 2RXi Pharmaceuticals and MirImmune LLC Enter into an Exclusive Licensing Agreement for RXi's Self-Delivering RNAi (sd-rxRNA) Technology to Develop Cell-based Immunotherapies to Treat Cancer 2RXi Pharmaceuticals and MirImmune LLC Enter into an Exclusive Licensing Agreement for RXi's Self-Delivering RNAi (sd-rxRNA) Technology to Develop Cell-based Immunotherapies to Treat Cancer 3RXi Pharmaceuticals and MirImmune LLC Enter into an Exclusive Licensing Agreement for RXi's Self-Delivering RNAi (sd-rxRNA) Technology to Develop Cell-based Immunotherapies to Treat Cancer 4RXi Pharmaceuticals and MirImmune LLC Enter into an Exclusive Licensing Agreement for RXi's Self-Delivering RNAi (sd-rxRNA) Technology to Develop Cell-based Immunotherapies to Treat Cancer 5Visceral Pain Pipeline Review H1 2015 Market Research Report 2Visceral Pain Pipeline Review H1 2015 Market Research Report 3Visceral Pain Pipeline Review H1 2015 Market Research Report 4
... Award winner Gloria Gaynor -- whose hit songs have captivated ... AARP,s Orlando@50+ National Event & Expo to raise ... this potentially debilitating condition. This high profile event, with an ... at the Orange County Convention Center in Orlando, ...
... Laureate Pharma, Inc., a full-service biopharmaceutical development ... appointment of Steven R. Johnson as Vice ... responsible for Laureate,s worldwide business development activities, ... management, supporting the company,s contract development, protein ...
Cached Medicine Technology:Gloria Gaynor to Appear at AARP's Orlando@50+ National Event & Expo 2Laureate Pharma Appoints Steven R. Johnson as Vice President, Business Development 2
(Date:3/28/2015)... 28, 2015 How best to treat ... field in orthopaedic medicine. While diagnostic hip injections are ... the pain etiology, research presented today at the American ... Day suggests that pain relief from this diagnostic injection ... , “Our study looked to assess if the ...
(Date:3/28/2015)... NC (PRWEB) March 28, 2015 Genomic ... with peritoneal mesothelioma, revealing, for the first time, key ... Click here to read the newly posted story ... at the University of British Columbia, the British Columbia ... genome mapping to reveal underlying molecular alterations and mutations ...
(Date:3/28/2015)... 2015 Aureus Medical Group (web: ... physical therapy jobs, has announced that it will ... Therapy Association Annual Conference to be held April ... in Columbus, OH. , The OPTA Annual ... with products and services. , Representatives from ...
(Date:3/28/2015)... Viejo, California (PRWEB) March 28, 2015 ... announced a new overlay entitled Scratches 5K from Pixel ... grungy scratch effects to any media inside Final Cut ... Studios. “StoryBoard Corporate saves time and is an effective ... media using FCPX Overlay Scratches 5K's intuitive grunge overlays. ...
(Date:3/28/2015)... CA (PRWEB) March 28, 2015 ... specialists , this week released a report about the ... symptoms of asthma sufferers, and according to recent medical ... , According to the Environmental Protection Agency, people ... asthmatic reactions. Breathing in mold may trigger asthma attacks ...
Breaking Medicine News(10 mins):Health News:Pain Injections for Hip Arthroscopy Patients May Not Predict Surgical Outcomes 2Health News:New Genomics Research May Help Doctors Tailor Mesothelioma Treatment, According to Surviving Mesothelioma 2Health News:Healthcare Staffing Leader, Aureus Medical Group, to Exhibit at the Ohio Physical Therapy Association Annual Conference 2Health News:Pixel Film Studios Unveiled Scratches 5k for Final Cut Pro X Editors 2Health News:Water Damage Restoration Specialists Servpro of Paso Robles Release Report on Mold and Asthma 2Health News:Water Damage Restoration Specialists Servpro of Paso Robles Release Report on Mold and Asthma 3
... , NEW YORK, Aug. 14 MS ... conducted by AstraZeneca, found that while most patients with asthma ... act accordingly. , , "This finding ... asthma and the necessary steps people should take to achieve ...
... ... present a technology and admissions educational session for THCA members , ... Atlanta, GA (PRWEB) August 14, 2009 ... providers, announced today that it will present a session at the Tennessee Health Care ...
... ... collision avoidance method used in uncontrolled areas, risks inherent in such situations , ... San Mateo, CA (Lexis Nexis) August 14, ... August 8th, in which nine people were killed when a small aircraft collided in midair ...
... , SACRAMENTO, Calif., Aug. 13 The ... million to the Healthy Families Program today to cover health care costs ... due to the state,s fiscal crisis. The funding, approved at a special ... 0-5 through June 2010. , , "In the current ...
... ... of Sexual Health in His New Book ,Ultimate Sexual Health & Performance, , ... Los Angeles, California (Vocus) August 13, 2009 ... his book ,Ultimate Sexual Health & Performance., Bringing over 35 years of research and ...
... , , JACKSON, Miss., Aug. 13 ... benefits for speech therapy services, The Mississippi School Boards Association and ... the new Medicaid claiming policy for the coming school year . ... by school providers, which are in fact still claimable. Specifically, ...
Cached Medicine News:Health News:Keeping Asthma Under Control 2Health News:Patient Placement Systems Presents a Session at the THCA 2009 Annual Convention 2Health News:Patient Placement Systems Presents a Session at the THCA 2009 Annual Convention 3Health News:Midair Collision over Hudson Provides Tragic Reminder that Airplanes and Helicopters Don't Mix Well, According to Aviation Law Expert 2Health News:First 5 California Approves $81.4 Million Contribution to Help Restore Healthy Families Program's Viability 2Health News:Definitive Sexual Health Book Released 2Health News:Definitive Sexual Health Book Released 3Health News:Mississippi School Boards Association and Accelify Attain Clarity on New Medicaid Claiming Policy for Coming School Year 2Health News:Mississippi School Boards Association and Accelify Attain Clarity on New Medicaid Claiming Policy for Coming School Year 3
... ORTHOSET Radiopaque Bone Cement consists ... a sterile,ampule containing bone cement ... and a sterile polyethylene bag,containing ... peelable pouch. The interiors of ...
... Bone Cement consists of a ... containing bone cement liquid within ... sterile polyethylene bag,containing bone cement ... The interiors of the blister ...
A "doughy" type of bone cement intended for manual application....
... as a recessed scratch-resistant sapphire lens and ... arthroscope has superior clarity and durability. Sterilization ... steam autoclaving or soaked in glutaraldehyde solutions.,Available ... ACMI, Wolf, Dyonics and Storz type light ...
Medicine Products: